Anti-Folate Receptor alpha-directed Antibody Therapies Restrict the Growth of Triple Negative Breast Cancer

Cheung, A; Opzoomer, JW; Ilieva, KM; Gazinska, P; Hoffmann, RM; Mirza, H; Marlow, R; ... Karagiannis, SN; + view all Cheung, A; Opzoomer, JW; Ilieva, KM; Gazinska, P; Hoffmann, RM; Mirza, H; Marlow, R; Francesch-Domenech, E; Fittall, MW; Dominguez Rodriguez, D; Clifford, A; Badder, L; Patel, N; Mele, S; Pellizzari, G; Bax, HJ; Crescioli, S; Petranyi, G; Larcombe-Young, D; Josephs, DH; Canevari, S; Figini, M; Pinder, SE; Nestle, FO; Gillett, C; Spicer, J; Grigoriadis, A; Tutt, A; Karagiannis, SN; - view fewer (2018) Anti-Folate Receptor alpha-directed Antibody Therapies Restrict the Growth of Triple Negative Breast Cancer. Clinical Cancer Research 10.1158/1078-0432.CCR-18-0652 . (In press).

https://ift.tt/2xq0YNw